| Bellevue Global Life Science Investors LLC |
OSRH |
Common Stock |
Other |
2.15% |
|
|
43,000 |
2,043,500 |
14 Feb 2025 |
Direct |
| Kuk Hyoun Hwang |
OSRH |
Common Stock |
Other |
32.6% |
|
|
3,123,970 |
12,699,104 |
14 Feb 2025 |
By Bellevue Capital Management LLC |
| Kuk Hyoun Hwang |
OSRH |
Common Stock |
Other |
368.6% |
|
|
7,531,634 |
9,575,134 |
14 Feb 2025 |
By BCM Europe AG |
| Kuk Hyoun Hwang |
OSRH |
Common Stock |
Other |
2.15% |
|
|
43,000 |
2,043,500 |
14 Feb 2025 |
By Bellevue Global Life Sciences Investors LLC |
| Bellevue Global Life Science Investors LLC |
OSRH |
Common Stock |
Other |
-0.99% |
|
|
-20,000 |
2,000,500 |
23 Mar 2023 |
Direct |
| Bellevue Global Life Science Investors LLC |
OSRH |
Warrant for Common Stock |
Other |
-5.13% |
|
|
-20,000 |
370,000 |
23 Mar 2023 |
Direct |
| Kuk Hyoun Hwang |
OSRH |
Common Stock |
Other |
-0.99% |
|
|
-20,000 |
2,000,500 |
23 Mar 2023 |
By Bellevue Global Life Sciences Investors LLC |
| Kuk Hyoun Hwang |
OSRH |
Warrant for Common Stock |
Other |
-5.13% |
|
|
-20,000 |
370,000 |
23 Mar 2023 |
By Bellevue Global Life Sciences Investors LLC |
| David Jin Yoo |
OSRH |
Common Stock |
Award |
|
|
|
20,000 |
20,000 |
23 Mar 2023 |
Direct |
| David Jin Yoo |
OSRH |
Warrant for Common Stock |
Award |
|
|
|
20,000 |
20,000 |
23 Mar 2023 |
Direct |
| Kuk Hyoun Hwang |
OSRH |
Common Stock |
Other |
-0.22% |
|
|
-4,500 |
2,020,500 |
21 Feb 2023 |
By Bellevue Global Life Sciences Investors LLC |
| Kuk Hyoun Hwang |
OSRH |
Common Stock |
Other |
12.5% |
|
|
225,000 |
2,025,000 |
21 Feb 2023 |
By Bellevue Global Life Sciences Investors LLC |
| Bellevue Global Life Science Investors LLC |
OSRH |
Common Stock |
Other |
-0.22% |
|
|
-4,500 |
2,020,500 |
21 Feb 2023 |
Direct |
| Bellevue Global Life Science Investors LLC |
OSRH |
Common Stock |
Other |
12.5% |
|
|
225,000 |
2,025,000 |
21 Feb 2023 |
Direct |
| In Chul Chung |
OSRH |
Common Stock |
Award |
|
|
|
20,000 |
20,000 |
14 Feb 2023 |
Direct |
| In Chul Chung |
OSRH |
Warrant for Common Stock |
Award |
|
|
|
20,000 |
20,000 |
14 Feb 2023 |
Direct |
| Rad Roberts |
OSRH |
Common Stock |
Award |
|
|
|
20,000 |
20,000 |
14 Feb 2023 |
Direct |
| Jin Whan Park |
OSRH |
Common Stock |
Award |
|
|
|
20,000 |
20,000 |
14 Feb 2023 |
Direct |
| Hosun Euh |
OSRH |
Common Stock |
Award |
|
|
|
20,000 |
20,000 |
14 Feb 2023 |
Direct |
| Bellevue Global Life Science Investors LLC |
OSRH |
Common Stock |
Other |
-20.6% |
|
|
-355,000 |
1,370,000 |
14 Feb 2023 |
Direct |
| Bellevue Global Life Science Investors LLC |
OSRH |
Common Stock |
Award |
31.4% |
|
|
430,000 |
1,800,000 |
14 Feb 2023 |
Direct |
| Bellevue Global Life Science Investors LLC |
OSRH |
Private Placement Warrants |
Purchase |
|
|
|
430,000 |
430,000 |
14 Feb 2023 |
Direct |
| Bellevue Global Life Science Investors LLC |
OSRH |
Warrant for Common Stock |
Other |
-9.3% |
|
|
-40,000 |
390,000 |
14 Feb 2023 |
Direct |
| Kuk Hyoun Hwang |
OSRH |
Common Stock |
Other |
-20.6% |
|
|
-355,000 |
1,370,000 |
14 Feb 2023 |
By Bellevue Global Life Sciences Investors LLC |
| Kuk Hyoun Hwang |
OSRH |
Common Stock |
Award |
31.4% |
|
|
430,000 |
1,800,000 |
14 Feb 2023 |
By Bellevue Global Life Sciences Investors LLC |
| Kuk Hyoun Hwang |
OSRH |
Warrant for Common Stock |
Other |
-9.3% |
|
|
-40,000 |
390,000 |
14 Feb 2023 |
By Bellevue Global Life Sciences Investors LLC |
| Kuk Hyoun Hwang |
OSRH |
Private Placement Warrants |
Purchase |
|
|
|
430,000 |
430,000 |
14 Feb 2023 |
By Bellevue Global Life Sciences Investors LLC |
| Steven Reed |
OSRH |
Common Stock |
Award |
|
|
|
20,000 |
20,000 |
14 Feb 2023 |
Direct |
| Steven Reed |
OSRH |
Warrant for Common Stock |
Award |
|
|
|
20,000 |
20,000 |
14 Feb 2023 |
Direct |